Americas Adopt Regional Action Plan to Strengthen Response Against Antimicrobial Resistance
Washington, D.C.: Countries across the Americas have adopted a new regional action plan aimed at strengthening the fight against antimicrobial resistance (AMR), a growing public-health challenge that can make infections increasingly difficult to treat.

The initiative, coordinated through the Pan American Health Organization (PAHO), focuses on improving surveillance, responsible use of antimicrobial medicines, infection prevention and stronger health systems.
A growing global health challenge
Antimicrobial resistance occurs when bacteria, viruses, fungi or parasites change over time and no longer respond effectively to medicines designed to treat them.
When medicines become less effective, common infections can become harder to control and medical procedures can carry greater risks.
AMR can also increase healthcare costs and place additional pressure on hospitals and health systems.
Strengthening surveillance
One of the major priorities of the regional plan is improving monitoring of resistant infections.
Reliable surveillance data can help health authorities identify emerging resistance patterns and determine which medicines remain effective against particular infections.
Better information can also support national policies on antimicrobial prescribing and infection control.
Responsible use of medicines
The action plan places emphasis on using antimicrobial medicines appropriately.
Antibiotics, for example, are effective against bacterial infections but do not treat viral illnesses such as most common colds and influenza.
Unnecessary or inappropriate use can contribute to the development and spread of resistant bacteria.
Healthcare professionals therefore play an important role in ensuring that antimicrobial medicines are prescribed and used appropriately.
Infection prevention remains essential
Preventing infections can reduce the need for antimicrobial treatment in the first place.
Measures such as vaccination, hand hygiene, safe healthcare practices, sanitation and infection-control procedures can help reduce transmission of infectious diseases.
Hospitals are particularly important because resistant organisms can spread rapidly in healthcare environments.
A One Health approach
AMR is not limited to human healthcare.
Antimicrobial use in animals and agriculture can also contribute to the development and spread of resistant microorganisms.
The regional response therefore supports a One Health approach, linking human health, animal health, food systems and the environment.
Research and innovation
The development of new antibiotics and other treatments remains an important part of the response.
However, new medicines alone cannot solve antimicrobial resistance. They must be combined with responsible use, effective surveillance and prevention measures.
Research into rapid diagnostic tests can also help doctors determine whether infections are bacterial and which medicines are likely to work.
Cooperation across countries
Antimicrobial-resistant organisms can cross national borders through travel, trade, migration and other forms of movement.
Regional cooperation therefore allows countries to share surveillance information, coordinate policies and exchange technical expertise.
The new action plan seeks to strengthen this cooperation across the Americas.
Long-term public-health priority
The fight against antimicrobial resistance requires sustained action rather than a short-term response.
Improving healthcare practices, strengthening laboratory capacity, expanding surveillance and promoting responsible antimicrobial use can help slow the spread of resistance.
The new regional plan provides countries across the Americas with a framework for coordinating these efforts while addressing the growing threat to public health.